Introduction

Mihai Gheorghiade*, Gerasimos S. Filippatos, Gregg C. Fonarow, Stefan D. Anker

*Corresponding author for this work

Research output: Contribution to journalEditorialpeer-review

1 Scopus citations
Original languageEnglish (US)
Pages (from-to)S1-S2
JournalAmerican Journal of Cardiology
Volume101
Issue number11 SUPPL.
DOIs
StatePublished - Jun 2 2008

Funding

Gregg C. Fonarow, MD , has served as a consultant for Amgen Inc., AstraZeneca Pharmaceuticals, Bristol-Myers Squibb, GlaxoSmithKline, Medtronic, Inc., Merck & Co., Inc., NitroMed, Inc., Otsuka Pharmaceutical Co., Pfizer Inc, sanofi-aventis, Schering-Plough, and Scios, Inc.; has received research/grant support from Amgen Inc., GlaxoSmithKline, Medtronic, Inc., the National Institutes of Health (NIH), Pfizer Inc, and Scios. Inc.; and has received honoraria from Abbott Laboratories, Amgen Inc., AstraZeneca Pharmaceuticals, Bristol-Myers Squibb, GlaxoSmithKline, King, Inc., Merck & Co., Inc., NitroMed, Inc., Pfizer Inc, sanofi-aventis, Schering-Plough, and Scios, Inc.

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this